Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2007

View Archived Issues

Summit and Evolva to codevelop new drugs for infectious diseases

Update on Protalex's phase I trial of PRTX-100

Positive results for AVI-5126 cardiovascular restenosis preventer

BioLineRx begins phase II trial of BL-1020 for schizophrenia

GSK declines option to develop Exelixis compound XL-647 licensed to SEI

Osiris and Genzyme to codevelop Prochymal for ARS

Siga and USAMRIID identify small-molecule inhibitors of Filoviridae viral entry

Abbott discloses novel antiviral agents in recent patent

Pyrazoline-based SARM with strong anabolic and partial androgenic/antiandrogenic effects in rats

Intranasal immunization with VLP vaccine protects against pandemic flu virus

Trypanosoma vaccine candidates comprised of tubulin peptides and mosaic virus

Genzyme reports second quarter 2007 results

CSL Behring announces FDA approval of Privigen

Omrix submits appplication to the EMEA for marketing approval of Evicel

Lybrel, first low-dose combination oral contraceptive now available in the U.S.

Safety and tolerability of HPV16 E6E7 vaccine reported in HIV-positive, HPV-infected patients

Significant antiviral activity with etravirine in HIV-positive, NNRTI-resistant patients

Fully human MAbs effective against highly pathogenic avian influenza virus

Positive results for Intellect's single-dose phase Ia trial of Oxigon

OSI transfers all rights to E-10030 and PDGF program to Ophthotech

ImClone and Bristol-Myers expand Erbitux codevelopment agreement

Positive preclinical results for Gene Logic's GL-1001 for IBD

Abbott begins phase I study of ABT-560 for CNS disorders

Epix presents new 5-HT6 receptor antagonist with beneficial effects in animal model of schizophrenia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...